Wednesday, September 16, 2015

New Analysis of Paxil Data: Were Adverse Events Downplayed? (CME/CE)

(MedPage Today) -- Fresh look at infamous Study 329 raises questions about pharma transparency
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)